These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 4909447)

  • 1. Clinical trial of Theograd.
    Brantingham P
    Br J Clin Pract; 1970 Apr; 24(4):165-7. PubMed ID: 4909447
    [No Abstract]   [Full Text] [Related]  

  • 2. [Obstructive airway diseases. Basic therapy with pure theophylline in retard form].
    Pollert I
    Fortschr Med; 1982 Mar; 100(12):547-50. PubMed ID: 7042500
    [No Abstract]   [Full Text] [Related]  

  • 3. A comparative assessment of choline theophyllinate and sustained-release theophylline in patients attending a chest clinic.
    McIntosh D
    Br J Clin Pract; 1971 May; 25(5):233-5. PubMed ID: 5580693
    [No Abstract]   [Full Text] [Related]  

  • 4. [Nebetol in the treatment of bronchial asthma and chronic obstructive bronchitis].
    Popovac D; Spasić P; Vukcević G
    Plucne Bolesti; 1985; 37(1-2):106-9. PubMed ID: 3906721
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapy of chronic obstructive respiratory syndrome with the new theophylline preparation Afonilum retard].
    Dettmer HH
    Fortschr Med; 1981 Jul; 99(25):1007-11. PubMed ID: 7262783
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical experiences with delayed action Perspiran in obstructive respratory disorders].
    Dlouhy R
    Med Welt; 1967 Aug; 33():1918-21. PubMed ID: 5590200
    [No Abstract]   [Full Text] [Related]  

  • 7. [Experiences in the treatment of bronchospastic diseases].
    Klein HG
    Med Welt; 1967 Nov; 45():2718-21. PubMed ID: 5609213
    [No Abstract]   [Full Text] [Related]  

  • 8. [Use of a corticosteroid with prolonged action in the treatment of chronic respiratory insufficiency secondary to "chronic obstructive pulmonary disease"].
    Scatola L
    Minerva Med; 1966 Oct; 57(79):3191-7. PubMed ID: 5926098
    [No Abstract]   [Full Text] [Related]  

  • 9. Sustained-release theophylline preparations.
    Drug Ther Bull; 1985 May; 23(9):33-6. PubMed ID: 3888583
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical experiences with a new drug association with anti-asthmatic action].
    Martelli A
    Clin Ter; 1967 Jun; 41(6):529-44. PubMed ID: 4387419
    [No Abstract]   [Full Text] [Related]  

  • 11. [Therapeutic action of a drug with constant and prolonged release (Netaprina Dospan) in the treatment of various obstructive broncho-pneumopathies].
    Fontana A; Ballerini G
    Policlinico Prat; 1970 Sep; 77(39):1247-54. PubMed ID: 4394634
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical trial of a sustained release theophylline tablet in adult asthmatics.
    Dhand R; Malik SK; Garg SK; Bhutani JK; Swaminathan S
    Indian J Chest Dis Allied Sci; 1986; 28(4):212-21. PubMed ID: 3301644
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of a bronchodilator-expectorant elixir in obstructive pulmonary disease.
    Simson G; Bronstein S
    J Am Geriatr Soc; 1966 Mar; 14(3):258-63. PubMed ID: 5325536
    [No Abstract]   [Full Text] [Related]  

  • 14. [The spirographically controlled treatment of the chronic nonspecific respiratory syndrome].
    Pichler O
    Wien Med Wochenschr; 1971 Mar; 121(12):223-6. PubMed ID: 5556377
    [No Abstract]   [Full Text] [Related]  

  • 15. The efficacy of sustained release theophylline (Pro-Vent), in asthma.
    Wallis PJ; Joy M; Hughes DT; Empey DW
    Br J Clin Pract; 1985 Sep; 39(9):341-5. PubMed ID: 3904796
    [No Abstract]   [Full Text] [Related]  

  • 16. [Controlled study of 3 sulfonamides in chronic urinary and bronchial infections].
    Piolino M; de Kalbermatten JP; Dobjanski S; Granato D; Schelling JL
    Schweiz Med Wochenschr; 1968 Nov; 98(44):1756-62. PubMed ID: 4884544
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacokinetics and pharmacodynamics of three sustained-release theophylline preparations (350 mg Theograd, 350 mg Theolair Retard and 300 mg Theodur) in steady state in healthy volunteers and asthmatics--Part I: Theophylline plasma levels.
    van der Vet AP; Drost RH; Kreukniet J; Maes RA
    Int J Clin Pharmacol Ther Toxicol; 1984 Aug; 22(8):423-9. PubMed ID: 6490224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in the fibre system and viscosity of the sputum of bronchitis during treatment with bromhexine and guaiphenesin (guaiacol glyceryl ether).
    Bürgi H
    Scand J Respir Dis Suppl; 1974; 90():81-5. PubMed ID: 4618378
    [No Abstract]   [Full Text] [Related]  

  • 19. Computer-assisted oral and intravenous theophylline therapy.
    Mungall D; Bancroft W; Marshall J
    Comput Biomed Res; 1982 Feb; 15(1):18-28. PubMed ID: 7060363
    [No Abstract]   [Full Text] [Related]  

  • 20. [Polysomnographic measurements in early and late administration (18.00 vs. 22.00 hours) of retarded theophylline in bronchial asthma].
    Rühle KH; Horn H; Hagenmeier A; Würtemberger G; Schmitz-Schumann M; Matthys H
    Prax Klin Pneumol; 1987 May; 41(5):180-6. PubMed ID: 3299354
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.